239
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Perioperative ω-3 Polyunsaturated Fatty Acid Nutritional Support in Gastrointestinal Cancer Surgical Patients: A Systematic Evaluation

, , &
Pages 568-576 | Received 19 Feb 2015, Accepted 29 Dec 2015, Published online: 26 Apr 2016

References

  • Horgan A: Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Tech Coloproctol 18, 1137–1138, 2014.
  • Rosa F, Bossola M, Pacelli F, Alfieri S, and Doglietto GB: Malnutrition and postoperative complications in abdominal surgery. Ann Surg 254, 666; author reply 666–667, 2011.
  • Cerantola Y, Hubner M, Grass F, Demartines N, and Schafer M: Immunonutrition in gastrointestinal surgery. Br J Surg 98, 37–48, 2011.
  • Calder PC: Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 75, 645–662, 2013.
  • Manna S, Janarthan M, Ghosh B, Rana B, Rana A, et al.: Fish oil regulates cell proliferation, protect DNA damages and decrease HER-2/neu and c-Myc protein expression in rat mammary carcinogenesis. Clin Nutr 29, 531–537, 2010.
  • Seyfried TN, and Shelton LM: Cancer as a metabolic disease. Nutr Metab (Lond) 7, 269–270, 2010.
  • Macasek J, Vecka M, Zak A, Urbanek M, Krechler T, et al.: Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. Nutr Cancer 64, 946–955, 2012.
  • Arshad A, Chung WY, Isherwood J, Mann CD, Al-Leswas D, et al.: Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer. Clin Nutr 33, 895–899, 2014.
  • Yang P, Cartwright C, Chan D, Ding J, Felix E, et al.: Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation. Mol Carcinog 53, 566–577, 2014.
  • Sorensen LS, Thorlacius-Ussing O, Schmidt EB, Rasmussen HH, Lundbye-Christensen S, et al.: Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery. Br J Surg 101, 33–42, 2014.
  • Maruyama T, Mimura K, Izawa S, Shiba S, Watanabe M, et al.: Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer. Nutrition 27, 146–152, 2011.
  • Seyfried TN, Flores RE, Poff AM, and D'Agostino DP: Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis 35, 515–527, 2014.
  • Weiss G, Meyer F, Matthies B, Pross M, Koenig W, et al.: Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr 87(Suppl 1), S89–S94, 2002.
  • Giger-Pabst U, Lange J, Maurer C, Bucher C, Schreiber V, et al.: Short-term preoperative supplementation of an immunoenriched diet does not improve clinical outcome in well-nourished patients undergoing abdominal cancer surgery. Nutrition 29, 724–729, 2013.
  • Lobo DN, Williams RN, Welch NT, Aloysius MM, Nunes QM, et al.: Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a prospective, randomized, controlled, double-blind study. Clin Nutr 25, 716–726, 2006.
  • Sultan J, Griffin SM, Di Franco F, Kirby JA, Shenton BK, et al.: Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 99, 346–355, 2012.
  • Higgins JPT and Green S (eds). Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://www.cochrane-handbook.org.
  • Daly JM, Weintraub FN, Shou J, Rosato EF, and Lucia M: Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 221, 327–338, 1995.
  • Schilling J, Vranjes N, Fierz W, Joller H, Gyurech D, et al.: Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition 12, 423–429, 1996.
  • Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, et al.: A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122, 1763–1770, 2002.
  • Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, et al.: Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 111, 611–616, 2004.
  • Nakamura K, Kariyazono H, Komokata T, Hamada N, Sakata R, et al.: Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer. Nutrition 21, 639–649, 2005.
  • Farreras N, Artigas V, Cardona D, Rius X, Trias M, et al.: Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr 24, 55–65, 2005.
  • Okamoto Y, Okano K, Izuishi K, Usuki H, Wakabayashi H, et al.: Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg 33, 1815–1821, 2009.
  • Suzuki D, Furukawa K, Kimura F, Shimizu H, Yoshidome H, et al.: Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy. Surgery 148, 573–581, 2010.
  • Klek S, Sierzega M, Szybinski P, Szczepanek K, Scislo L, et al.: The immunomodulating enteral nutrition in malnourished surgical patients—a prospective, randomized, double-blind clinical trial. Clin Nutr 30, 282–288, 2011.
  • Marano L, Porfidia R, Pezzella M, Grassia M, Petrillo M, et al.: Clinical and immunological impact of early postoperative enteral immunonutrition after total gastrectomy in gastric cancer patients: a prospective randomized study. Ann Surg Oncol 20, 3912–3918, 2013.
  • Aida T, Furukawa K, Suzuki D, Shimizu H, Yoshidome H, et al.: Preoperative immunonutrition decreases postoperative complications by modulating prostaglandin E2 production and T-cell differentiation in patients undergoing pancreatoduodenectomy. Surgery 155, 124–133, 2014.
  • Wei Z, Wang W, Chen J, Yang D, Yan R, et al.: A prospective, randomized, controlled study of omega-3 fish oil fat emulsion-based parenteral nutrition for patients following surgical resection of gastric tumors. Nutr J 13, 25, 2014.
  • Mantovani G, Maccio A, Madeddu C, Serpe R, Massa E, et al.: Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist 15, 200–211, 2010.
  • Ma YJ, Yu J, Xiao J, and Cao BW: The consumption of omega-3 polyunsaturated Fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: a systematic evaluation. Nutr Cancer 67, 112–118, 2015.
  • Di Carlo V, Gianotti L, Balzano G, Zerbi A, and Braga M: Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg 16, 320–326, 1999.
  • Koch T, and Heller AR: Benefits of ω-3 fatty acids in parenteral nutrition. Clin Nutr Suppl 1, 17–24, 2005.
  • Caglayan K, Oner I, Gunerhan Y, Ata P, Koksal N, et al.: The impact of preoperative immunonutrition and other nutrition models on tumor infiltrative lymphocytes in colorectal cancer patients. Am J Surg 204, 416–421, 2012.
  • Tilley SL, Coffman TM, and Koller BH: Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108, 15–23, 2001.
  • American Cancer Society. Cancer facts & figures 2013. Atlanta, GA: American Cancer Society, 2013.
  • Rogers ES, MacLeod RD, Stewart J, Bird SP, and Keogh JW: A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients—ACCeRT study. BMC Cancer 11, 493, 2011.
  • Liang B, Wang S, Ye YJ, Yang XD, Wang YL, et al.: Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol 14, 2434–2439, 2008.
  • de Miranda Torrinhas RSM, Santana R, Garcia T, Cury-Boaventura MF, Sales MM, et al.: Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer. Clin Nutr 32, 503–510, 2013.
  • Kondrup J, Rasmussen HH, Hamberg O, and Stanga Z: Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22, 321–336, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.